
Molecule: LOKIVETMAB
ChEMBL ID: CHEMBL5315070
Mechanism of Action: BINDING AGENT
Max Phase: -1.0
Molecule Type: Antibody
First Approval: 2017

Molecule: VIXARELIMAB
ChEMBL ID: CHEMBL4594341
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: NEMOLIZUMAB
ChEMBL ID: CHEMBL4297794
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody
